Physician profile
Melissa Kellogg Schultz
NPI 1891859633
$4,225.39
in general payments reported to CMS, 2019-2025
13 companies · $1,090 in 2025
The $1,090 reported for 2025 was more than what 92% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.82 · 2022: $690 · 2023: $1,915 · 2024: $507 · 2025: $1,090.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,583 · Travel and Lodging: $929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,583.39 |
| Travel and Lodging | $928.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $2,020.58 | 2022-2025 | Acuvue |
| Sun Pharmaceutical Industries INC. | $404.07 | 2022-2025 | Cequa |
| Bausch & Lomb Americas INC. | $336.87 | 2022-2025 | Miebo, Infuse, Alden Scleral Zenlens |
| Alcon Vision LLC | $299.81 | 2023-2025 | Tryptyr, Dailies Total1, Total30 |
| Tarsus Pharmaceuticals, INC. | $279.13 | 2024-2025 | Xdemvy |
| Coopervision INC. | $277.12 | 2019-2025 | Clariti Contact Lens, Ortho-K Contact Lens, Misight Contact Lens |
| Sight Sciences, INC. | $185.41 | 2024-2025 | Omni Surgical System, Tearcare System |
| Oyster Point Pharma, INC. | $123.70 | 2023-2024 | Tyrvaya |
| Regeneron Healthcare Solutions, INC. | $121.30 | 2025 | Eylea Hd |
| Dompe US, INC. | $80.44 | 2024-2025 | Oxervate |
| Abbvie INC. | $47.75 | 2023 | Alphagan P, Vuity, Lumigan |
| Lombart Brothers, INC. | $25.31 | 2022 | |
| Novartis Pharmaceuticals Corporation | $23.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Schultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.